We have further verified this interaction, with flow cytometry, western blot and mRNA expression analysis in the colon cancer cell-line DLD-1 by showing that knock-out of AKT1, AKT2 or both AKT1 and AKT2 increased the expression of CD44. This evidence concerns the gene CD44 and malignant colon neoplasm.